• Tech Launch Perspective
    July 22, 2026

    Life sciences enterprises are moving beyond isolated generative AI pilots toward governed, multi-agent workflows that support clinical, commercial, and real-world activities. This shift is increasing demand for platforms that combine regulatory-grade data governance, enterprise interoperability, scalable…
  • Blog
    March 13, 2024

    Though a recent Everest Group survey revealed the pressing need for mainframe modernization, the technology is far from dead in the banking, financial services, and insurance (BFSI) industry. The rise of generative AI (gen AI) will…